Related references
Note: Only part of the references are listed.Pharmacokinetic considerations for pediatric patients receiving analgesia in the intensive care unit; targeting postoperative, ECMO and hypothermia patients
Gerdien A. Zeilmaker et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
Chie Emoto et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling
Iftekhar Mahmood et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
Tomoyuki Mizuno et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Morphine Pharmacodynamics in Mechanically Ventilated Preterm Neonates Undergoing Endotracheal Suctioning
P. A. Valitalo et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future
A. S. Darwich et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity
Elisha M. Wachman et al.
AMERICAN JOURNAL ON ADDICTIONS (2017)
Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on-line SPE-LC-MS/MS
Ruth Verplaetse et al.
DRUG TESTING AND ANALYSIS (2016)
Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates
Stephanie Leroux et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Therapeutic drug monitoring in neonates
Steven Pauwels et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2016)
Clinical Decision Support Tools: The Evolution of a Revolution
D. R. Mould et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years A Randomized Clinical Trial
Giancarlo Natalucci et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling
Janneke M. Brussee et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group
K. L. R. Brouwer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Modeling and Simulation in Pediatric Drug Therapy: Application of Pharmacometrics to Define the Right Dose for Children
A. A. Vinks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
LC-MS/MS bioanalysis of loratadine (Claritin) in dried blood spot (DBS) samples collected by subjects in a clinical research study
Wenkui Li et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling
Jian Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dosing in neonates: special considerations in physiology and trial design
Lawrence C. Ku et al.
PEDIATRIC RESEARCH (2015)
Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program
Brenda B. Poindexter et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Age-Dependent Changes in Sirolimus Metabolite Formation in Patients With Neurofibromatosis Type 1
Chie Emoto et al.
THERAPEUTIC DRUG MONITORING (2014)
Physiologically Based Pharmacokinetic Models in the Prediction of Oral Drug Exposure Over the Entire Pediatric Age Range-Sotalol as a Model Drug
Feras Khalil et al.
AAPS JOURNAL (2014)
Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
Rick Admiraal et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2014)
Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization
Jeannine S. McCune et al.
CLINICAL CANCER RESEARCH (2014)
Evidence-Based Morphine Dosing for Postoperative Neonates and Infants
Elke H. J. Krekels et al.
CLINICAL PHARMACOKINETICS (2014)
Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications
Julie Autmizguine et al.
DRUGS (2014)
Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics
Kevin J. Downes et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Neonatal clinical pharmacology
Karel Allegaert et al.
PEDIATRIC ANESTHESIA (2014)
Why is there no morphine concentration-response curve for acute pain?
Brian J. Anderson et al.
PEDIATRIC ANESTHESIA (2014)
Effect of UGT2B7-900G > A (-842G > A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohort
Maja Matic et al.
PHARMACOGENOMICS (2014)
Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype
Maja Matic et al.
PHARMACOGENOMICS (2014)
CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
Maria Johansson et al.
FRONTIERS IN GENETICS (2014)
Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
A. R. Maharaj et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools
Aline Fuchs et al.
CLINICAL PHARMACOKINETICS (2013)
Developmental expression of drug metabolizing enzymes: Impact on disposition in neonates and young children
R. N. Hines
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Federal Legislation and the Advancement of Neonatal Drug Studies
Jason R. Wiles et al.
JOURNAL OF PEDIATRICS (2013)
Application of Physiologically Based Pharmacokinetic Modeling to Predict Acetaminophen Metabolism and Pharmacokinetics in Children
X-L Jiang et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
H. M. Jones et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers
Wei Zhao et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Assessment of paper spray ionization for quantitation of pharmaceuticals in blood spots
Nicholas E. Manicke et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2011)
Fluconazole Loading Dose Pharmacokinetics and Safety in Infants
Lauren Piper et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Practical, Individualized Dosing: 21st Century Therapeutics and the Clinical Pharmacometrician
Michael Neely et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Understanding the Relative Roles of Pharmacogenetics and Ontogeny in Pediatric Drug Development and Regulatory Science
J. Steven Leeder et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?
Xavier Durrmeyer et al.
PLOS ONE (2010)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants
Kelly C. Wade et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Population Pharmacokinetics of Fluconazole in Young Infants
K. C. Wade et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pharmacokinetic and pharmacodynamic variability: A daunting challenge in drug therapy
Jiunn H. Lin
CURRENT DRUG METABOLISM (2007)
Whole-body physiologically based pharmacokinetic models
Ivan Nestorov
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Prediction of drug clearance in children from adults: a comparison of several allometric methods
I Mahmood
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Development and evaluation of a generic physiologically based pharmacokinetic model for children
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2006)
Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P4502C8 and 2C9 amino acid polymorphisms
E García-Martín et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Developmental pharmacology - Drug disposition, action, and therapy in infants and children
GL Kearns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Achieving target goals most precisely using nonparametric compartmental models and multiple model design of dosage regimens
R Jelliffe et al.
THERAPEUTIC DRUG MONITORING (2000)
Share Paper
